1.11CAD
27.51 MCAD
28.56 MCAD
12.94 M
About CIPHER PHARMACEUTICALS INC
Sector
CEO
Craig Mull
Headquarters
Mississauga
Website
Founded
2000
ISIN
CA17253X1050
FIGI
BBG000BSKPS7
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Mississauga, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CPH is 8.82 CAD — it has decreased by 1.01% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange CIPHER PHARMACEUTICALS INC stocks are traded under the ticker CPH.
CIPHER PHARMACEUTICALS INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for CIPHER PHARMACEUTICALS INC has a max estimate of 9.26 CAD and a min estimate of 8.01 CAD.
CPH earnings for the last quarter are 0.37 CAD whereas the estimation was 0.10 CAD which accounts for 285.71% surprise. Estimated earnings for the next quarter are 0.13 CAD. See more details about CIPHER PHARMACEUTICALS INC earnings.
CIPHER PHARMACEUTICALS INC revenue for the last quarter amounts to 8.24 M CAD despite the estimated figure of 7.13 M CAD. In the next quarter revenue is expected to reach 6.94 M CAD.
Yes, you can track CIPHER PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, CPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CIPHER PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CIPHER PHARMACEUTICALS INC EBITDA is 15.19 M CAD, and current EBITDA margin is 53.21%. See more stats in CIPHER PHARMACEUTICALS INC financial statements.